Skip to main content
. 2021 Aug 10;112(10):4176–4186. doi: 10.1111/cas.15089

FIGURE 3.

FIGURE 3

POU4F2 is a tumor promotor in CRC cell lines. A, B , Wound healing ability of POU4F2‐knockdown HCT116 (A) and POU4F2‐knockdown RKO (B) cells. C, D, Migration and invasion abilities of POU4F2‐knockdown HCT116 (C) and POU4F2‐knockdown RKO (D) cells. E, F , Expression of E‐cadherin and vimentin proteins in POU4F2‐knockdown HCT116 (E) and POU4F2‐knockdown RKO (F) cells. G, H, Expression of EMT‐TFs in POU4F2‐knockdown HCT116 (G) and POU4F2‐knockdown RKO (H) cells. All experiments were performed in triplicate. Data were presented as the mean ± SEM (*P < .05, **P < .01, ***P < .001, ****P < .0001)